Mail

UK markets closed

FTSE 100
8,213.49
+41.34(+0.51%)
FTSE 250
20,164.54
+112.21(+0.56%)
AIM
771.53
+3.42(+0.45%)
GBP/EUR
1.1652
-0.0031(-0.26%)
GBP/USD
1.2546
+0.0013(+0.11%)
Bitcoin GBP
50,244.72
+2,806.80(+5.92%)

Best savings accounts that offer above inflation rates

Where to find a top-rated deal that works for you

Microbot Medical Inc. (MBOT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD

Add to watchlist

0.9798

-0.0108

(-1.09%)

At close: 04:00PM EDT

0.9850

+0.01

(+0.53%)

After hours:

04:34PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	14.11M
Enterprise value	7.95M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	N/A
Price/book (mrq)	3.13
Enterprise value/revenue	N/A
Enterprise value/EBITDA	-0.79

Trading information

Stock price history

Beta (5Y monthly)	1.65
52-week change ³	-13.04%
S&P500 52-week change ³	22.38%
52-week high ³	4.3700
52-week low ³	0.8600
50-day moving average ³	1.1302
200-day moving average ³	1.4625

Share statistics

Avg vol (3-month) ³	100.13k
Avg vol (10-day) ³	104.91k
Shares outstanding ⁵	14.4M
Implied shares outstanding ⁶	14.4M
Float ⁸	14.15M
% held by insiders ¹	1.68%
% held by institutions ¹	12.27%
Shares short (15 Apr 2024) ⁴	255.37k
Short ratio (15 Apr 2024) ⁴	2.49
Short % of float (15 Apr 2024) ⁴	2.01%
Short % of shares outstanding (15 Apr 2024) ⁴	1.77%
Shares short (prior month 15 Mar 2024) ⁴	89.63k

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	05 Sept 2018
Ex-dividend date ⁴	N/A
Last split factor ²	1:15
Last split date ³	05 Sept 2018

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	0.00%
Operating margin (ttm)	0.00%

Management effectiveness

Return on assets (ttm)	-68.96%
Return on equity (ttm)	-182.19%

Income statement

Revenue (ttm)	N/A
Revenue per share (ttm)	N/A
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	N/A
EBITDA	-9.75M
Net income avi to common (ttm)	-10.74M
Diluted EPS (ttm)	-1.0500
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	6.38M
Total cash per share (mrq)	0.44
Total debt (mrq)	231k
Total debt/equity (mrq)	5.13%
Current ratio (mrq)	2.09
Book value per share (mrq)	0.38

Cash flow statement

Operating cash flow (ttm)	-8.53M
Levered free cash flow (ttm)	-3.81M